Blastic plasmacytoid dendritic cell neoplasm: challenges in diagnosis and treatment with potential of venetoclax as an alternative to vincristine in high-risk patients—a case report
Abstract Background Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and challenging cancer for diagnosis and treatment. Accurate diagnosis plays a crucial role guiding appropriate treatment, typically involving high-intensity lymphoblastic leukemia regimens which typically include vin...
Main Authors: | Naveed Syed, Waed Mohammad Jaber, Islam Samir Elkonaissi, Imran Mirza, Moussab Damlaj |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2023-08-01
|
Series: | Bulletin of the National Research Centre |
Subjects: | |
Online Access: | https://doi.org/10.1186/s42269-023-01094-x |
Similar Items
-
Venetoclax monotherapy as front-line therapy for blastic plasmacytoid dendritic cell neoplasm
by: Ankit Mitesh Shah, et al.
Published: (2023-01-01) -
Dermatoscopic features of blastic plasmacytoid dendritic cell neoplasm: a case report and review of the literature
by: Daniel Argüello-Ruiz, et al.
Published: (2024-10-01) -
Venetoclax combined with azacitidine in blastic plasmacytoid dendritic cell neoplasm: a case report and comprehensive review on the current and future treatment
by: Xiaoning Wang, et al.
Published: (2024-07-01) -
Blastic plasmacytoid dendritic cell neoplasm: a short review and update
by: Cesare Massone, et al.
Published: (2023-08-01) -
A Rare Case of Blastic Plasmacytoid Dendritic Cell Neoplasm in a Child Mimicking Lymphoma/Leukemia Cutis
by: Phanitchanat Phusuphitchayanan, et al.
Published: (2022-09-01)